Zhuoli N. Zhang

No. 8, Xishiku Street
Beijing, 100034, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 117 publications

Adult-onset retinoblastoma in a 17-year-old girl: a case report

Adult-onset retinoblastoma in a 17-year-old girl: a case report

Journal: [Zhonghua yan ke za zhi] Chinese journal of ophthalmology
Published: September 07, 2026

IRE1/p‑JNK/NRF2 axis-mediated GPX4 upregulation underlies ferroptosis resistance in rheumatoid arthritis fibroblast-like synoviocytes.

IRE1/p‑JNK/NRF2 axis-mediated GPX4 upregulation underlies ferroptosis resistance in rheumatoid arthritis fibroblast-like synoviocytes.

Journal: Arthritis research & therapy
Published: March 05, 2026

Prospective Quantification of Glucocorticoid Toxicity Across Dosage Ranges in Systemic Lupus Erythematosus: Insights from the Glucocorticoid Toxicity Index.

Prospective Quantification of Glucocorticoid Toxicity Across Dosage Ranges in Systemic Lupus Erythematosus: Insights from the Glucocorticoid Toxicity Index.

Journal: Rheumatology and therapy
Published: March 04, 2026

Are RAS inhibitors necessary during intensive immunosuppression for lupus nephritis? Real-world evidence from the STAR cohort.

Are RAS inhibitors necessary during intensive immunosuppression for lupus nephritis? Real-world evidence from the STAR cohort.

Journal: Lupus science & medicine
Published: February 25, 2026

Interferon-induced protein 44-like promoter Hypomethylation as an epigenetic hallmark of systemic lupus erythematosus.

Interferon-induced protein 44-like promoter Hypomethylation as an epigenetic hallmark of systemic lupus erythematosus.

Journal: Journal of translational medicine
Published: February 14, 2026

CAR-T therapy for autoimmune rheumatic diseases: navigating clinical frontiers between breakthroughs and uncertainties.

CAR-T therapy for autoimmune rheumatic diseases: navigating clinical frontiers between breakthroughs and uncertainties.

Journal: Clinical and experimental medicine
Published: December 06, 2025

Refractory lupus nephritis: current Understanding and emerging treatment strategies.

Refractory lupus nephritis: current Understanding and emerging treatment strategies.

Journal: Clinical and experimental medicine
Published: November 12, 2025

Validation of the Systemic Lupus Erythematosus Disease Activity Score (SLE-DAS) in a Chinese Cohort: Comparison with SLEDAI-2-K.

Validation of the Systemic Lupus Erythematosus Disease Activity Score (SLE-DAS) in a Chinese Cohort: Comparison with SLEDAI-2-K.

Journal: Rheumatology and therapy
Published: November 05, 2025

National and provincial burden of interstitial lung disease mortality in China, 2013-2021: a nationwide analysis of trends and underlying cause of death.

National and provincial burden of interstitial lung disease mortality in China, 2013-2021: a nationwide analysis of trends and underlying cause of death.

Journal: Respiratory research
Published: October 10, 2025

Redefining Initial Rheumatoid Arthritis Treatment: Tofacitinib Outperforms Methotrexate in Disease Control-An Open-Label Randomized Controlled Trial.

Redefining Initial Rheumatoid Arthritis Treatment: Tofacitinib Outperforms Methotrexate in Disease Control-An Open-Label Randomized Controlled Trial.

Journal: Mayo Clinic proceedings
Published: September 25, 2025

Overcoming challenges: magnetic resonance imaging in the detection and monitoring of rare prostate involvement in granulomatosis with polyangiitis.

Overcoming challenges: magnetic resonance imaging in the detection and monitoring of rare prostate involvement in granulomatosis with polyangiitis.

Journal: Clinical and experimental rheumatology
Published: August 02, 2025

Evolution of gut microbiota in psoriatic arthritis treated with IL-17 inhibitor revealed by metagenomics.

Evolution of gut microbiota in psoriatic arthritis treated with IL-17 inhibitor revealed by metagenomics.

Journal: Joint bone spine
Published: October 24, 2024
Showing 1-12 of 117

Last Updated: 09/26/2026